Details of the Drug

General Information of Drug (ID: DMDW5QN)

• Drug Name: BI 891065

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 1	[1]

• Drug Type: Small molecular drug
• Cross-matching ID: TTD ID: D2V4YI

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)